ClinicalTrials.gg
RecruitingNCT07665034IRE-HTUpdated Oct 30, 2026

Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

An interventional study of Squatting Exercise and Stretching (Yoga) Exercise in Atherosclerosis Cardiovascular Disease, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Apr 2025, registered Sep 2025).
  • Started Apr 2025; still recruiting 1 year 6 months later.
Updated Oct 30, 2026Eligibility revisedStudy contact changedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Background:

Hypertension (HT) is the most common condition worldwide, predisposing to atherosclerotic disease. However, most HT patients have suboptimal BP control despite anti-HT medications. Isometric resistance exercise (IRE) (e.g. wall squat) may improve BP control, characterized by sustained muscle contraction with minimal change in muscle length and joint angle. Most randomized trials of IRE are short duration and their long-term effects on BP and atherosclerotic complications, particularly in the Chinese, remain unknown.

Study objectives:

(i) To evaluate the impact of IRE on atherogenesis surrogates (brachial flow-mediated dilation, FMD and carotid intima-media thickness IMT).

(ii) To evaluate the impact of IRE on mechanisms of atherogenesis improvement, inflammatory parameters, arterial wall stiffness and biochemical profiles.

Setting:

Randomized samples of 200 HT patients, aged >18years with systolic BP 135-160mHg while on no or stable anti-HT medications.

Design: Randomized controlled IRE trial - stratified randomization with randomization block size of 4.

  1. 100 patients for wall squat exercise of 14 mins each session (2 mins IRE x 4 sets, 2 mins rest in between), 3 sessions per week, for 1 year, plus advice on healthy diet and lifestyle.
  2. 100 control patients (usual care) with advice on diet and healthy lifestyles and simple stretching exercise programme for 1 year.

Main outcome measures:

  1. Brachial FMD and carotid IMT at baseline, 24 weeks and 1 year. (primary outcome)
  2. Carotid-femoral pulse wave velocity (cf-PWV) at baseline and 24 weeks. (secondary outcome)
  3. Important atherosclerosis risk factor parameters at baseline, 24 weeks and 1 year - including fasting serum glucose, lipid profiles, HgbA1-C, creatinine, hs-CRP, CBP, fibrinogen, and interleukin 6 (IL-6). (secondary outcome)
  4. Safety profiles (if any) including CVS event and hospitalization at 1 year.

Expected results:

A group absolute difference in FMD of 1%, and in carotid IMT of 0.06mm between IRE intervention and control groups.

Implications: IRE as suggested will be beneficial to management of HT for atherosclerosis preventions.

Read the detailed description
  1. Introduction

    Hypertension (HT) is the most common condition worldwide predisposing to atherosclerotic diseases (stroke, heart attack and peripheral vascular disease), apart from other traditional risk factors [1-3]. However, most HT patients have suboptimal BP control despite anti-HT medications [4]. On this issue, aerobic and dynamic exercise are effective in BP-reduction, but HT-patients often have poor compliance with exercise, mainly because of requirement of additional time, skill training, venue and equipments [5-6]. Isometric resistance exercised (IRE) (e.g. wall squat) may improve BP control, characterized by sustained muscle contractions with minimal change in muscle length and joint angle. However, most randomized trials of IRE have short duration and their long-term effect on BP-reduction, mechanisms and atherosclerosis complications, particularly in the Chinese, remain unknown [7-11].

    Much advance in noninvasive vessel-imaging has been witnessed in past few decades. Brachial flow-mediated dilation (FMD) and carotid intima-media thickness (IMT), have been advocated as surrogate markers for the documentation of early atherosclerosis and evaluation of preventive measures (12-20). Both brachial FMD and carotid IMT can now be measured accurately with high reproducibility, and have been related to cardiovascular outcomes. In clinical context, a 0.1mm increase in carotid IMT has been associated with 41% increase in stroke and 43% increase in acute myocardial infarction over a follow-up period of 2-7 years. [17] An 8% difference in carotid IMT was approximately similar to the kind of difference seen between diabetes and non-diabetes Chinese adults [21).

  2. Aims and Hypotheses to be Tested

    Systemic hypertension has been proven accelerating atherosclerotic process. To further test this initial hypothesis, this interventional substudy aims:

    (i) To evaluate the impact of IRE on atherosclerotic surrogates (brachial FMD and carotid IMT).

    (ii) To evaluate the impact of IRE on mechanisms of BP and atherogenesis reductions, including endothelial function FMD, carotid IMT and arterial wall stiffness (cfPWV), and inflammatory parameters.

  3. Plan of Investigation The brachial FMD and carotid IMT before and after IRE intervention will be compared between the wall-squat and control intervention groups.

3.1 The impact of Isometric resistance exercise (IRE) Intervention on brachial FMD and carotid IMT.

Subjects:

200 HT adults, aged >18 years with SBP 135-160mmHg on AMBP will be recruited. Those with incapacitating osteoarthritis of knee and secondary HT will be excluded.

3.2 Methods: These HT participants will be randomized to practise IRE (100 adults) 14 mins per session, (2 mins IRE x 4sets, 2 mins rest in between), 3 sessions per week, or usual standard care \& stretching (yoga) exercise (100 adults).

Week-0 \~ Health Examination, Randomization (IRE vs Yoga), Vascular Study (FMD \& IMT), Blood Test, and Arterial wall stiffness (cfPWV)

Week-13 \~ Compliance (adhenence) checking

Week-24 \~ Health Examination, vascular study (FMD \& IMT), blood tests, and arterial wall stiffness (cfPWV)

One Year \~ Compliance (adherence) checking, vascular study (FMD \& IMT), vessel wall stiffness, and blood Tests

  • Collection of health data:

    1. Questionnaire - All adult subjects will be interviewed and required to complete a detailed questionnaire regarding their individual and family history of cardiovascular diseases, hypertension, diabetes and current use of medications. Information on socio-economic status, tobacco use and lifestyle will be collected.
    2. Health examination - Each participant will receive a health examination and their weight and height, blood pressures, body mass index (BMI) and wait-hip circumference ratio (WHR) will be measured (light clothing and no shoes).
    3. Blood tests: 10ml of fasting blood will be taken for WBC platelet, fasting glucose, HgbA1C, low density lipoprotein cholesterol, hsC-reactive protein, fibrinogen and IL-6.
  • Vascular Studies:

Endothelial function, flow-mediated dilation (FMD) of the brachial artery and carotid IMT will be studied by using high resolution ultrasound.

(i) Endothelial function, (brachial flow-mediated dilation, FMD) will be studied by using high resolution ultrasound, as described previously. [12,22-24] In brief, the diameter of the brachial artery will be measured on B-mode ultrasound images, using a linear array transducer (HF L38) with a median frequency of 13-6MHz and a standard Sonosite (MicroMaxx) system. Forearm tourniquet cuff placement will be applied to induce reactive hyperemia on deflation. Scans of brachial artery 10cm proximal to elbow will be acquired at rest, during reactive hyperemia (to induce flow-mediated endothelium-dependent dilation, FMD). FMD will be expressed as % of dilation from baseline vessel diameter normalized with vessel strain. Hyperemia is calculated as the % increase in blood flow after cuff deflation compared with baseline.

(ii) Carotid intima-media thickness (CIMT) measurement - B-mode ultrasound examinations will be performed using a 10-5 probe, with a 7.5 MHz scanning frequency linear array transducer. All carotid scans will be performed by a single operator after a predetermined, standardized scanning protocol for the right and left carotid arteries as described by Salonen and Salonen [16] and Touboul et al [19], using images of the far wall of the distal 10 mm of the common carotid arteries. All scans will be recorded on super-VHS videotape for subsequent off-line analysis for intima-media thickness (IMT), using a verified automatic edge-detecting and measurement software package as described previously. [19-24] The intra-observer variability of mean IMT is 0.003 to 0.011mm (CV 0.998%).

3.3 Outcomes

3.3.1 Primary outcomes: Vascular Parameters: Brachial FMD (%) and Carotid IMT (mm) at baseline, 24 weeks and 1 year.

3.3.2 Secondary outcomes: (i) Carotid femoral pulse wave velocity, cfPWV (mm/sec) at baseline and 24 weeks.

(ii) Other important traditional atherosclerosis risk factors: BMI (weight kg/ height m\^2), glucose (mmol/l), lipid profiles (mmol/l), HgbA1-C (%), creatinine (umol/L), haemoglobin (g/dl), hsCRP (mg/l), Fibrinogen (mg/dl) and IL-6 (pg/ml) at baseline, 24 weeks and 1 year.

3.3.3 Safety profiles (if any) including CVS event and hospitalization at 1 year,

4. Compliance with Declaration of Helsinki. The design, methodology and conduction of project are in compliance with Declaration of Helsinki.

5. Data processing and analysis:

(5.1) Power Calculation: The SPSS version 28 was used to calculate the sample size for FMD and carotid IMT. Data from our previous studies on Chinese adults in Hong Kong reported FMD was in 6-8% +/- 1.3%, and carotid IMT was 0.55-0.68mm +/- 0.1mm. On the assumption of post IRE brachial FMD will improve to 6.7-8.7 +/- 1.4%, and carotid IMT will reduce to 0.51-0.61mm +/- 0.11mm, recruitment of 200 Chinese adults (100 in each group) will be adequately powered (85%) to detect a group difference in brachial FMD of 1.2% and in carotid IMT of 0.06mm (12%), at 1 year between the two treatment groups.

(5.2). Data Analysis: Statistical Analysis System SPSS version 28 will be used for all statistical analyses. Descriptive methods will be used to describe characteristics of cardiovascular risks. The primary endpoints are AMBP, brachial FMD and carotid IMT; serological inflammatory biomarkers (Neutrophil/ monocyte ratio and Platelet), hsCRP, fibrinogen and IL-6 are secondary endpoints. Students' T-tests will be used to detect the group differences in brachial FMD and carotid IMT. Multivariable linear and logistic regressions will be used to calculate the risk magnitude by IRE vs usual care and stretching exercise interventions, and to control potential confounders such as traditional cardiovascular risk factors.

02

Conditions studied

  • Atherosclerosis Cardiovascular Disease

Keywords

  • Isometric Resistance Exercise
  • Essential Hypertension
  • Atherosclerosis
  • Brachial FMD
  • Carotid IMT
  • Atherosclerosis Prevention
03

In context

Essential Hypertension

478 studies on the registry are indexed under Essential Hypertension; 74 are open to participants now.

This study's planned enrollment of 200 is above the median of 144 across 406 interventional studies indexed under Essential Hypertension.

Browse Essential Hypertension studies →

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,454 studies on the registry; 474 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Oct 30, 2026. See what changed

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. asymptomatic clinically stable adults
  2. aged >18 years
  3. No regular physical activites
  4. Suboptimal BP (on stable medication) with SBP 135-160mmHG on ambulatory BP monitoring (AMBP)
  5. Agreeable to no drug changes during the interventional period (24 weeks)
  6. Agreeable to provide informed written consent form
  7. Agreeable to have AMBP and ultrasonic (FMD \& IMT) scan thrice (baseline, 24 weeks and preferably 1 year)

Exclusion criteria

Exclusion Criteria:

  1. relative to AMBP (e.g. atrial fibrillation)
  2. severe osteoarthritis of knee
  3. known secondary HT
  4. Systolic BP >160 mmHg or diastolic BP >100 mmHg on ABBP monitoring at baseline or at 12 weeks follow up (to ensure safety)
  5. Resistant HT, require > 3 anti-HT medications at maximum doses, or > 4 medications for BP control
  6. pregnancy/breastfeeding
  7. active
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Active comparator
    Anti HT + Isometric Resistance Squatting Exercise (100 Adults)

    A more linear thigh-leg squatting angle is allowed in initial 2 weeks, but aiming at 90 degree thigh-leg angle after 4 weeks.

    Other: Squatting Exercise

  • Active comparator
    Anti HT + Stretching Exercise (100 Adults)

    A liberal leg stretching excerise will be practised

    Other: Stretching (Yoga) Exercise

Interventions

  • OtherSquatting Exercise

    14 minutes per session (2 mins x 4 sets, 2 mins rest in between, 3 session per week)

  • OtherStretching (Yoga) Exercise

    2 mins x 4 sets, 2 mins rest in between, 3 sessions per week

06

What researchers measure

Primary outcomes

  1. The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Changes in Brachial FMD (%)

    Time frame: Baseline, 24 weeks and 1 year

  2. The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Changes in Carotid IMT (mm)

    Time frame: Baseline, 24 weeks and 1 year

Secondary outcomes

  1. The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Changes in Carotid femoral pulse wave velocity, cfPWV (mm/sec)

    Time frame: Baseline and 24 weeks

  2. The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Other important traditional atherosclerosis risk factors: Changes in BMI (weight kg/ height m\^2)

    Time frame: Baseline, 24 weeks and 1 year

  3. The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Changes in Fasting Glucose (mmol/l)

    Time frame: Baseline, 24 weeks and 1 year

  4. The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Changes in Fasting Lipid profiles (mmol/l) 1. Changes in high density lipoprotein cholesterol (HDL-C) (mmol/l) 2. Changes in low density lipoprotein cholesterol (LDL-C) (mmol/l) 3. Changes in Triglyceride (TG) (mmol/l)

    Time frame: Baseline, 24 weeks and 1 year

  5. The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    HgbA1-C (%)

    Time frame: Baseline, 24 weeks and 1 year

  6. The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Creatinine (umol/L)

    Time frame: Baseline, 24 weeks and 1 year

  7. The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Haemoglobin (g/dl)

    Time frame: Baseline, 24 weeks and 1 year

  8. The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    hsCRP (mg/l)

    Time frame: Baseline, 24 weeks and 1 year

  9. The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    Fibrinogen (mg/dl)

    Time frame: Baseline, 24 weeks and 1 year

  10. The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

    IL-6 (pg/ml)

    Time frame: Baseline, 24 weeks and 1 year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Hassen Abate K, Akinyemiju TF, Ali R, Alvis-Guzman N, Azzopardi P, Banerjee A, Barnighausen T, Basu A, Bekele T, Bennett DA, Biadgilign S, Catala-Lopez F, Feigin VL, Fernandes JC, Fischer F, Gebru AA, Gona P, Gupta R, Hankey GJ, Jonas JB, Judd SE, Khang YH, Khosravi A, Kim YJ, Kimokoti RW, Kokubo Y, Kolte D, Lopez A, Lotufo PA, Malekzadeh R, Melaku YA, Mensah GA, Misganaw A, Mokdad AH, Moran AE, Nawaz H, Neal B, Ngalesoni FN, Ohkubo T, Pourmalek F, Rafay A, Rai RK, Rojas-Rueda D, Sampson UK, Santos IS, Sawhney M, Schutte AE, Sepanlou SG, Shifa GT, Shiue I, Tedla BA, Thrift AG, Tonelli M, Truelsen T, Tsilimparis N, Ukwaja KN, Uthman OA, Vasankari T, Venketasubramanian N, Vlassov VV, Vos T, Westerman R, Yan LL, Yano Y, Yonemoto N, Zaki ME, Murray CJ. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA. 2017 Jan 10;317(2):165-182. doi: 10.1001/jama.2016.19043. PubMed 28097354 ↗
  • Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, Kazmi K, Lanas F, Wei L, Lopez-Jaramillo P, Fanghong L, Ismail NH, Puoane T, Rosengren A, Szuba A, Temizhan A, Wielgosz A, Yusuf R, Yusufali A, McKee M, Liu L, Mony P, Yusuf S; PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013 Sep 4;310(9):959-68. doi: 10.1001/jama.2013.184182. PubMed 24002282 ↗
  • Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr, Whitsel L, Kaufman JD; American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010 Jun 1;121(21):2331-78. doi: 10.1161/CIR.0b013e3181dbece1. Epub 2010 May 10. PubMed 20458016 ↗
  • Lee EKP, Poon P, Yip BHK, Bo Y, Zhu MT, Yu CP, Ngai ACH, Wong MCS, Wong SYS. Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta-Analysis Involving 27 Million Patients. J Am Heart Assoc. 2022 Sep 6;11(17):e026582. doi: 10.1161/JAHA.122.026582. Epub 2022 Sep 3. PubMed 36056737 ↗
  • Moncion K, Biasin L, Jagroop D, Bayley M, Danells C, Mansfield A, Salbach NM, Inness E, Tang A. Barriers and Facilitators to Aerobic Exercise Implementation in Stroke Rehabilitation: A Scoping Review. J Neurol Phys Ther. 2020 Jul;44(3):179-187. doi: 10.1097/NPT.0000000000000318. PubMed 32516297 ↗
  • Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002 Apr 2;136(7):493-503. doi: 10.7326/0003-4819-136-7-200204020-00006. PubMed 11926784 ↗
  • Smart NA, Gow J, Bleile B, Van der Touw T, Pearson MJ. An evidence-based analysis of managing hypertension with isometric resistance exercise-are the guidelines current? Hypertens Res. 2020 Apr;43(4):249-254. doi: 10.1038/s41440-019-0360-1. Epub 2019 Nov 22. PubMed 31758166 ↗
  • Hansford HJ, Parmenter BJ, McLeod KA, Wewege MA, Smart NA, Schutte AE, Jones MD. The effectiveness and safety of isometric resistance training for adults with high blood pressure: a systematic review and meta-analysis. Hypertens Res. 2021 Nov;44(11):1373-1384. doi: 10.1038/s41440-021-00720-3. Epub 2021 Aug 12. PubMed 34385688 ↗
  • Loaiza-Betancur AF, Chulvi-Medrano I. Is Low-Intensity Isometric Handgrip Exercise an Efficient Alternative in Lifestyle Blood Pressure Management? A Systematic Review. Sports Health. 2020 Sep/Oct;12(5):470-477. doi: 10.1177/1941738120943882. Epub 2020 Aug 10. PubMed 32776866 ↗
  • Smart NA, Way D, Carlson D, Millar P, McGowan C, Swaine I, Baross A, Howden R, Ritti-Dias R, Wiles J, Cornelissen V, Gordon B, Taylor R, Bleile B. Effects of isometric resistance training on resting blood pressure: individual participant data meta-analysis. J Hypertens. 2019 Oct;37(10):1927-1938. doi: 10.1097/HJH.0000000000002105. PubMed 30889048 ↗
  • Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992 Nov 7;340(8828):1111-5. doi: 10.1016/0140-6736(92)93147-f. PubMed 1359209 ↗
  • Neunteufl T, Heher S, Katzenschlager R, Wolfl G, Kostner K, Maurer G, Weidinger F. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol. 2000 Jul 15;86(2):207-10. doi: 10.1016/s0002-9149(00)00857-2. No abstract available. PubMed 10913483 ↗
  • Herrington DM, Fan L, Drum M, Riley WA, Pusser BE, Crouse JR, Burke GL, McBurnie MA, Morgan TM, Espeland MA. Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter. J Cardiovasc Risk. 2001 Oct;8(5):319-28. doi: 10.1177/174182670100800512. PubMed 11702039 ↗
  • Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003 May 21;41(10):1769-75. doi: 10.1016/s0735-1097(03)00333-4. PubMed 12767663 ↗
  • Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991 Sep-Oct;11(5):1245-9. doi: 10.1161/01.atv.11.5.1245. PubMed 1911709 ↗
  • Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997 Sep 2;96(5):1432-7. doi: 10.1161/01.cir.96.5.1432. PubMed 9315528 ↗
  • O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999 Jan 7;340(1):14-22. doi: 10.1056/NEJM199901073400103. PubMed 9878640 ↗
  • Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Kownator S, Prati P, Rundek T, Taylor A, Bornstein N, Csiba L, Vicaut E, Woo KS, Zannad F; Advisory Board of the 3rd Watching the Risk Symposium 2004, 13th European Stroke Conference. Mannheim intima-media thickness consensus. Cerebrovasc Dis. 2004;18(4):346-9. doi: 10.1159/000081812. Epub 2004 Nov 2. PubMed 15523176 ↗
  • Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007 Jan 30;115(4):459-67. doi: 10.1161/CIRCULATIONAHA.106.628875. Epub 2007 Jan 22. PubMed 17242284 ↗
  • Thomas GN, Chook P, Qiao M, Huang XS, Leong HC, Celermajer DS, Woo KS. Deleterious impact of "high normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):739-43. doi: 10.1161/01.ATV.0000118015.26978.07. Epub 2004 Jan 22. PubMed 14739120 ↗
  • Woo KS, Robinson JT, Chook P, Adams MR, Yip G, Mai ZJ, Lam CW, Sorensen KE, Deanfield JE, Celermajer DS. Differences in the effect of cigarette smoking on endothelial function in chinese and white adults. Ann Intern Med. 1997 Sep 1;127(5):372-5. doi: 10.7326/0003-4819-127-5-199709010-00006. PubMed 9273828 ↗
  • Woo KS, Chook P, Raitakari OT, McQuillan B, Feng JZ, Celermajer DS. Westernization of Chinese adults and increased subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2487-93. doi: 10.1161/01.atv.19.10.2487. PubMed 10521379 ↗
  • (24) Woo KS, Chook P, Hu YJ, Wong MK, Yin YH, Li Albert Martin, Chan SW, Kwok CY Timothy and Celermajer DS. Age and Gender Specific Reference Values of Brachial Flow-mediated Dilation and Carotid Intima-media Thickness in CATHAY Study: Atherosclerosis Surrogate Markers in Chinese Adults. J Cardio and Vasc Med 2023;9:103.

Individual participant data

Plan to share: Yes — There is a plan to make IPD and related data dictionaries available. All IPD that underline results in a publication.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: These materials will be available and shared on reasonable requests to Prof KS Woo from January 2025 till 30 December 2027

Access criteria: These materials will be available and shared on reasonable requests to Prof KS Woo from January 2025 till 30 December 2027 (kamsangwoo@cuhk.edu.hk/ crec@cuhk.edu.hk)

09

Updates

1 registry update since Sep 25, 2026
Eligibility
2 inclusion criteria edited, 1 added, 1 removed; 2 exclusion criteria added, 2 removed
What changed in the criteria
Inclusion criteria
  • RemovedBoth genders
  • AddedNo regular physical activites
  • EditedAgreeable to no drug changes in coming 1 year during the interventional period (24 weeks)
  • EditedAgreeable to have AMBP and ultrasonic (FMD \& IMT) scan thirdthrice (baseline, 24 weeks and preferably 1 year)
Exclusion criteria
  • AddedSystolic BP >160 mmHg or diastolic BP >100 mmHg on ABBP monitoring at baseline or at 12 weeks follow up (to ensure safety)
  • AddedResistant HT, require > 3 anti-HT medications at maximum doses, or > 4 medications for BP control
  • RemovedSerious coronary profiles, (unstable angina), renal or hepatic derangement
  • RemovedNeed to change medications for control BP at 24 weeks ( SBP>160 mmHg)
Oct 30, 2026
Contact
Study contact changed: k•••@cuhk.edu.hk · •••4966→k•••@cuhk.edu.hk · •••4966. See the current contact
Oct 30, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • The Chinese University of Hong Kong, Department of Medicine & Therapeutics · Shatin, Hong KongContact k•••@cuhk.edu.hk · •••4966→k•••@cuhk.edu.hk · •••4966
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    Eligibility 2 inclusion criteria edited, 1 added, 1 removed; 2 exclusion criteria added, 2 removed
    What changed in the criteria
    Inclusion criteria
    • RemovedBoth genders
    • AddedNo regular physical activites
    • EditedAgreeable to no drug changes in coming 1 year during the interventional period (24 weeks)
    • EditedAgreeable to have AMBP and ultrasonic (FMD \& IMT) scan thirdthrice (baseline, 24 weeks and preferably 1 year)
    Exclusion criteria
    • AddedSystolic BP >160 mmHg or diastolic BP >100 mmHg on ABBP monitoring at baseline or at 12 weeks follow up (to ensure safety)
    • AddedResistant HT, require > 3 anti-HT medications at maximum doses, or > 4 medications for BP control
    • RemovedSerious coronary profiles, (unstable angina), renal or hepatic derangement
    • RemovedNeed to change medications for control BP at 24 weeks ( SBP>160 mmHg)
    Contact Study contact changed: k•••@cuhk.edu.hk · •••4966→k•••@cuhk.edu.hk · •••4966. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • The Chinese University of Hong Kong, Department of Medicine & Therapeutics · Shatin, Hong KongContact k•••@cuhk.edu.hk · •••4966→k•••@cuhk.edu.hk · •••4966
    + 1 other change: description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07665034
Responsible party
Kam Sang WOO (Adjunct Professor, Chinese University of Hong Kong) — Principal investigator
First posted
Jun 24, 2026
Start date
Apr 16, 2025
Primary completion
Jul 30, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Oct 30, 2026

Study contacts

KS Woo, MBBS,MD,FACC
Contact
kamsangwoo@cuhk.edu.hk
+852 26474966
Kam Sang Woo
principal investigator · Chinese University of Hong Kong

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion